BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8313493)

  • 1. Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection.
    Soleimanzadeh G; Edrissian GH; Movahhed-Danesh AM; Nadim A
    Bull World Health Organ; 1993; 71(6):759-62. PubMed ID: 8313493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endemic focus of visceral leishmaniasis in Meshkin-Shahr, east Azerbaijan province, north-west part of Iran and IFA serological survey of the disease in this area.
    Edrissian GH; Hafizi A; Afshar A; Soleiman-Zadeh G; Movahed-Danesh AM; Garoussi A
    Bull Soc Pathol Exot Filiales; 1988; 81(2):238-48. PubMed ID: 3046770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated visceral leishmaniasis surveillance system in primary care for children in Meshkin-Shahr district, north-western Islamic Republic of Iran.
    Mohebali M; Edrissian GH; Shirzadi MR; Hosseingholizadeh G; Pashaei MH; Ganji A; Zarei Z; Kousha A; Akhoundi B; Hajjaran H; Malekafzali H
    East Mediterr Health J; 2010 Oct; 16(10):1050-4. PubMed ID: 21222421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.
    Ashkan MM; Rahim KM
    Trop Doct; 2008 Jul; 38(3):186-8. PubMed ID: 18628558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of rK39 strip test for the diagnosis of visceral leishmaniasis in infants.
    Alborzi A; Rasouli M; Nademi Z; Kadivar MR; Pourabbas B
    East Mediterr Health J; 2006; 12(3-4):294-9. PubMed ID: 17037697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran.
    Mohebali M; Hamzavi Y; Edrissian GH; Forouzani A
    East Mediterr Health J; 2001 Nov; 7(6):912-7. PubMed ID: 15332732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kala-azar epidemic in Varanasi district, India.
    Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
    Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis (kala-azar) in Fars Province, Iran: study of 130 cases.
    Hashemi-Nasab A; Zadeh-Shirazi H
    J Trop Med Hyg; 1980 Jun; 83(3):119-22. PubMed ID: 7401218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kala-azar in Afghanistan.
    Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
    J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic tests in patients after clinical cure of visceral leishmaniasis.
    De Almeida Silva L; Romero HD; Prata A; Costa RT; Nascimento E; Carvalho SF; Rodrigues V
    Am J Trop Med Hyg; 2006 Oct; 75(4):739-43. PubMed ID: 17038704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kala-azar in Ballia district, Uttar Pradesh.
    Rao JS; Rahman SJ; Singh J; Singh SK
    J Commun Dis; 1992 Jun; 24(2):116-20. PubMed ID: 1344169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological, clinical and therapeutic features of pediatric kala-azar.
    Rahim KM; Ashkan MM
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):626-30. PubMed ID: 17882998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.